NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000000579

Registered date:31/03/2010

A psychosomatic study for the functions of ghrelin.

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedEating disorder
Date of first enrollment2001/04/01
Target sample size200
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Subjects for patient group are patients with eating disorder. Inpatients are participated from admission to six months after discharge and outpatients are participated for six months after first oral glucose tolerance test. The treatment consists of behavioral therapy, nutritional rehabilitation and medication. Oral glucose tolerance test is administered before treatment, during treatment and after treatment. Subjects for control group are healthy volunteers. Oral glucose tolerance test is administered.

Outcome(s)

Primary Outcomefeeding regulatory peptides(e.g.,ghrelin), eating behaviour, nutritional change
Secondary Outcome

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
GenderFemale
Include criteria
Exclude criteriaThe subjects are excluded if they had a history of alcohol abuse, substance abuse, gastrointestinal disease, diabetes mellitus or other metabolic diseases.

Related Information

Contact

public contact
Name
Address 8-35-1, Sakuragaoka, Kagoshima-City 890-8520, Japan Japan
Telephone 099-275-5751
E-mail
Affiliation Kagoshima University Graduate School of Medical and Dental Sciences Department of Behavioral Medicine
scientific contact
Name Akio Inui
Address 8-35-1, Sakuragaoka, Kagoshima-City 890-8520, Japan Japan
Telephone 099-275-5751
E-mail
Affiliation Kagoshima University Graduate School of Medical and Dental Sciences Department of Behavioral Medicine